HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

FR234938

FR234938 has good potential as a new type of anti-rheumatic and anti-inflammatory drug, by modulating host-defense concentrations of adenosine

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Imidazoles: 150
      - FR234938: 1
Organic Chemicals: 133
- Hydrocarbons: 1713
  - Cyclic Hydrocarbons: 97
    - Aromatic Hydrocarbons: 291
      - Polycyclic Aromatic Hydrocarbons: 2020
        Naphthalenes: 18
        FR234938: 1
Polycyclic Compounds: 6
- Polycyclic Aromatic Hydrocarbons: 2020
  - Naphthalenes: 18
    - FR234938: 1

Experts

1.	Fujii, Takashi: 1 article (03/2006)
2.	Kinoshita, Takayoshi: 1 article (03/2006)
3.	Kuno, Masako: 1 article (03/2006)
4.	Nakamura, Katsuya: 1 article (03/2006)
5.	Nakanishi, Isao: 1 article (03/2006)
6.	Nishio, Nobuya: 1 article (03/2006)
7.	Sato, Akihiro: 1 article (03/2006)
8.	Seki, Nobuo: 1 article (03/2006)
9.	Terasaka, Tadashi: 1 article (03/2006)
10.	Tsujimoto, Susumu: 1 article (03/2006)

Related Diseases

1.	Hypersensitivity (Allergy) 03/18/2006 - "FR234938 also inhibits anti-type II collagen delayed type hypersensitivity (DTH) in a dose-dependent manner, both in the presence and absence of recombinant human adenosine deaminase. "

Related Drugs and Biologics

1.	Collagen Type II (Type II Collagen)
2.	Adenosine Deaminase